KDev Investments AB, 10% Owner at Aprea Therapeutics, Inc. (APRE), sold 210,548 shares at $31.25 ($6.6M) on 2020-04-13, disclosed to the SEC on 2020-04-15.
Open-market sale of $6.6M APRE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.